Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000902664-25-001705
Filing Date
2025-04-07
Accepted
2025-04-07 17:19:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 13315
  Complete submission text file 0000902664-25-001705.txt   15099
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Subject) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-45947 | Film No.: 25819055
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address
MERUELO ALEX (Filed by) CIK: 0001075186 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: SCHEDULE 13D
SIC: 0000